Ken Griffin Cytokinetics Inc Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $619,762 - $727,936	-12,100 Reduced 5.22%	219,800 $11.6 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $13.9 Million - $21.9 Million	-291,400 Reduced 55.69%	231,900 $12.6 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $9.61 Million - $16.3 Million	-150,800 Reduced 22.37%	523,300 $36.7 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $15.8 Million - $49 Million	586,600 Added 670.4%	674,100 $56.3 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $589,200 - $732,200	20,000 Added 29.63%	87,500 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.52 Million - $1.89 Million	46,500 Added 221.43%	67,500 $2.2 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $803,976 - $1.1 Million	-24,100 Reduced 53.44%	21,000 $738,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $815,556 - $1.17 Million	22,800 Added 102.24%	45,100 $2.07 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $19,270 - $27,260	500 Added 2.29%	22,300 $1.08 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.